Mar 01, 2022, 00:37 am
Moderna on Thursday said it expects to sell at least $19 billion of its COVID-19 vaccine this year, after reporting fourth-quarter earnings that blew out analysts' earnings and revenue estimates.
The company's 2022 forecast for vaccine sales was $2 billion higher than its previous expectation. Moderna previously said it expected $17 billion in vaccine sales this year.
Moderna reported $4.9 billion in net income for the fourth quarter. The company sold $17.7 billion of its COVID vaccine in 2021, delivering 807 million vaccine doses worldwide. Moderna's revenue totaled $18.5 billion for 2021.
https://menafn.com/1103758754/Moderna-Pr...source=138
The company's 2022 forecast for vaccine sales was $2 billion higher than its previous expectation. Moderna previously said it expected $17 billion in vaccine sales this year.
Moderna reported $4.9 billion in net income for the fourth quarter. The company sold $17.7 billion of its COVID vaccine in 2021, delivering 807 million vaccine doses worldwide. Moderna's revenue totaled $18.5 billion for 2021.
https://menafn.com/1103758754/Moderna-Pr...source=138